Determining the anti-coagulant-independent anti-cancer effects of heparin

Saved in:
Bibliographic Details
Published in:British journal of cancer 2010-08, Vol.103 (4), p.593-594
Main Authors: Solari, V, Jesudason, E C, Turnbull, J E, Yates, E A
Format: Article
Language:English
Subjects:
631/67/1059
692/699/67
Anticoagulants - therapeutic use
Antineoplastic Agents - therapeutic use
Biomedical and Life Sciences
Biomedicine
Cancer Research
Drug Resistance
Epidemiology
Heparin - therapeutic use
Humans
Letter to the Editor
Molecular Medicine
Neoplasms - drug therapy
Oncology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53
cites cdi_FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53
container_end_page 594
container_issue 4
container_start_page 593
container_title British journal of cancer
container_volume 103
creator Solari, V
Jesudason, E C
Turnbull, J E
Yates, E A
description
doi_str_mv 10.1038/sj.bjc.6605808
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2939791</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2105685991</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53</originalsourceid><addsrcrecordid>eNp1kUtvEzEUhS0EatPCll3RqJuuJr22x68NEuoDKlViA2vLca4TjxJPsGeQ-PcYJU0pEhs_dD4f36NDyHsKcwpcX5d-vuj9XEoQGvQrMqOCs5Zqpl6TGQCoFgyDU3JWSl-vBrQ6IacMZKeB0hl5uMUR8zammFbNuMbGpTG2fnCraVOPbUxL3GFd0niQXPKYGwwB_ViaITRr3Lkc01vyJrhNwXeH_Zx8v7_7dvOlffz6-eHm02PrO6XHlnupjQAZnMCAAYIDyjrdCUexEwZUxwED41yIpdBLpaWTTnVOa1ETLgQ_Jx_3vrtpscWlr5Nlt7G7HLcu_7KDi_alkuLaroaflhlulKHV4OpgkIcfE5bRbmPxuKl5cZiKVZ02zFAqK3n5D9kPU041XYUoSMUZVGi-h3weSskYjqNQsH86sqW3tSN76Kg--PB3gCP-VEoFrvdAqVJaYX7-9r-WF_sXyY1TxqPlk_4bQkGnRw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>741067320</pqid></control><display><type>article</type><title>Determining the anti-coagulant-independent anti-cancer effects of heparin</title><source>Open Access: PubMed Central</source><creator>Solari, V ; Jesudason, E C ; Turnbull, J E ; Yates, E A</creator><creatorcontrib>Solari, V ; Jesudason, E C ; Turnbull, J E ; Yates, E A</creatorcontrib><identifier>ISSN: 0007-0920</identifier><identifier>EISSN: 1532-1827</identifier><identifier>DOI: 10.1038/sj.bjc.6605808</identifier><identifier>PMID: 20648011</identifier><identifier>CODEN: BJCAAI</identifier><language>eng</language><publisher>London: Nature Publishing Group UK</publisher><subject>631/67/1059 ; 692/699/67 ; Anticoagulants - therapeutic use ; Antineoplastic Agents - therapeutic use ; Biomedical and Life Sciences ; Biomedicine ; Cancer Research ; Drug Resistance ; Epidemiology ; Heparin - therapeutic use ; Humans ; Letter to the Editor ; Molecular Medicine ; Neoplasms - drug therapy ; Oncology</subject><ispartof>British journal of cancer, 2010-08, Vol.103 (4), p.593-594</ispartof><rights>The Author(s) 2010</rights><rights>Copyright Nature Publishing Group Aug 10, 2010</rights><rights>Copyright © 2010 Cancer Research UK 2010 Cancer Research UK</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53</citedby><cites>FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939791/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939791/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20648011$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Solari, V</creatorcontrib><creatorcontrib>Jesudason, E C</creatorcontrib><creatorcontrib>Turnbull, J E</creatorcontrib><creatorcontrib>Yates, E A</creatorcontrib><title>Determining the anti-coagulant-independent anti-cancer effects of heparin</title><title>British journal of cancer</title><addtitle>Br J Cancer</addtitle><addtitle>Br J Cancer</addtitle><subject>631/67/1059</subject><subject>692/699/67</subject><subject>Anticoagulants - therapeutic use</subject><subject>Antineoplastic Agents - therapeutic use</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cancer Research</subject><subject>Drug Resistance</subject><subject>Epidemiology</subject><subject>Heparin - therapeutic use</subject><subject>Humans</subject><subject>Letter to the Editor</subject><subject>Molecular Medicine</subject><subject>Neoplasms - drug therapy</subject><subject>Oncology</subject><issn>0007-0920</issn><issn>1532-1827</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2010</creationdate><recordtype>article</recordtype><recordid>eNp1kUtvEzEUhS0EatPCll3RqJuuJr22x68NEuoDKlViA2vLca4TjxJPsGeQ-PcYJU0pEhs_dD4f36NDyHsKcwpcX5d-vuj9XEoQGvQrMqOCs5Zqpl6TGQCoFgyDU3JWSl-vBrQ6IacMZKeB0hl5uMUR8zammFbNuMbGpTG2fnCraVOPbUxL3GFd0niQXPKYGwwB_ViaITRr3Lkc01vyJrhNwXeH_Zx8v7_7dvOlffz6-eHm02PrO6XHlnupjQAZnMCAAYIDyjrdCUexEwZUxwED41yIpdBLpaWTTnVOa1ETLgQ_Jx_3vrtpscWlr5Nlt7G7HLcu_7KDi_alkuLaroaflhlulKHV4OpgkIcfE5bRbmPxuKl5cZiKVZ02zFAqK3n5D9kPU041XYUoSMUZVGi-h3weSskYjqNQsH86sqW3tSN76Kg--PB3gCP-VEoFrvdAqVJaYX7-9r-WF_sXyY1TxqPlk_4bQkGnRw</recordid><startdate>20100810</startdate><enddate>20100810</enddate><creator>Solari, V</creator><creator>Jesudason, E C</creator><creator>Turnbull, J E</creator><creator>Yates, E A</creator><general>Nature Publishing Group UK</general><general>Nature Publishing Group</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7TO</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M7P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20100810</creationdate><title>Determining the anti-coagulant-independent anti-cancer effects of heparin</title><author>Solari, V ; Jesudason, E C ; Turnbull, J E ; Yates, E A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2010</creationdate><topic>631/67/1059</topic><topic>692/699/67</topic><topic>Anticoagulants - therapeutic use</topic><topic>Antineoplastic Agents - therapeutic use</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cancer Research</topic><topic>Drug Resistance</topic><topic>Epidemiology</topic><topic>Heparin - therapeutic use</topic><topic>Humans</topic><topic>Letter to the Editor</topic><topic>Molecular Medicine</topic><topic>Neoplasms - drug therapy</topic><topic>Oncology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Solari, V</creatorcontrib><creatorcontrib>Jesudason, E C</creatorcontrib><creatorcontrib>Turnbull, J E</creatorcontrib><creatorcontrib>Yates, E A</creatorcontrib><collection>SpringerOpen</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biological Science Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>British journal of cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Solari, V</au><au>Jesudason, E C</au><au>Turnbull, J E</au><au>Yates, E A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Determining the anti-coagulant-independent anti-cancer effects of heparin</atitle><jtitle>British journal of cancer</jtitle><stitle>Br J Cancer</stitle><addtitle>Br J Cancer</addtitle><date>2010-08-10</date><risdate>2010</risdate><volume>103</volume><issue>4</issue><spage>593</spage><epage>594</epage><pages>593-594</pages><issn>0007-0920</issn><eissn>1532-1827</eissn><coden>BJCAAI</coden><cop>London</cop><pub>Nature Publishing Group UK</pub><pmid>20648011</pmid><doi>10.1038/sj.bjc.6605808</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0007-0920
ispartof British journal of cancer, 2010-08, Vol.103 (4), p.593-594
issn 0007-0920
1532-1827
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2939791
source Open Access: PubMed Central
subjects 631/67/1059
692/699/67
Anticoagulants - therapeutic use
Antineoplastic Agents - therapeutic use
Biomedical and Life Sciences
Biomedicine
Cancer Research
Drug Resistance
Epidemiology
Heparin - therapeutic use
Humans
Letter to the Editor
Molecular Medicine
Neoplasms - drug therapy
Oncology
title Determining the anti-coagulant-independent anti-cancer effects of heparin
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T18%3A30%3A04IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Determining%20the%20anti-coagulant-independent%20anti-cancer%20effects%20of%20heparin&rft.jtitle=British%20journal%20of%20cancer&rft.au=Solari,%20V&rft.date=2010-08-10&rft.volume=103&rft.issue=4&rft.spage=593&rft.epage=594&rft.pages=593-594&rft.issn=0007-0920&rft.eissn=1532-1827&rft.coden=BJCAAI&rft_id=info:doi/10.1038/sj.bjc.6605808&rft_dat=%3Cproquest_pubme%3E2105685991%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c478t-3c689506fa5efef0fa0124845a1e45907430ef23355d58d786a6a74a885580b53%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=741067320&rft_id=info:pmid/20648011&rfr_iscdi=true